Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 275 Carcinoma, Intraductal, Noninfiltrating 25 Breast Carcinoma In Situ 21 Breast Neoplasms, Male 12 Neoplasm Metastasis 10 Neoplasms 7 Inflammatory Breast Neoplasms 7 Breast Cancer Female 4 Obesity 3 Endometrial Neoplasms 3 Carcinoma, Ductal, Breast 3 Breast Diseases 3 Sleep Wake Disorders 2 Hot Flashes 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Risk Reduction Behavior 1 Recurrence 1 Pulmonary Fibrosis 1 Primary Breast Cancer 1 Premenopausal Breast Cancer 1 Precancerous Conditions 1 Patient Acceptance of Health Care 1 Paget's Disease, Mammary 1 Ovarian Neoplasms 1

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 pembrolizumab 1 nazartinib 1 exemestane 1 canakinumab 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Sentinel Lymph Node Biopsy 1 Pemetrexed 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ductal × Tamoxifen × Breast × Clear all

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡